Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Theratechnologies submits IND application to Health Canada for ThGRF1-44

Aug. 10, 2001

Endorex acquires CTD and adds two clinical-stage products to its pipeline

Aug. 8, 2001

First kidney transplant patient enrolled in phase II trials of ISAtx-247

Aug. 8, 2001

Pfizer patents novel protein kinase inhibitors

Aug. 6, 2001

IND application submitted for Product R

Aug. 6, 2001

New tablet form of Rapamune for kidney transplants now available in the U.S.

Aug. 6, 2001

Novel adamantane derivatives and their use described by AstraZeneca

Aug. 3, 2001

Milestone achieved in MorphoSys/GPC Biotech immunology antibody program

July 31, 2001

FDA advisory committee reports results of FluMist evaluation

July 31, 2001

Immediate pain following i.m. injection of QS-21 may be alleviated with certain excipients

July 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...